[Federal Register Volume 64, Number 188 (Wednesday, September 29, 1999)]
[Notices]
[Pages 52530-52531]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-25359]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated May 26, 1999, and published in the Federal Register
on July 7, 1999, (64 FR 30359), Radian International LLC, 14050 Summit
Drive #121, P.O. Box 201088, Austin, Texas 78720-1088, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic classes of controlled
substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)............................. I
Methcathinone (1237)......................... I
N-Etylamphetamine (1475)..................... I
N,N-Dimethylamphetamine (1480)............... I
Aminorex (1585).............................. I
4-Methylaminorex (cis isomer) (1590)......... I
Methaqualone (2565).......................... I
Alpha-Ethyltryptamine (7249)................. I
Lysergic acid diethylamide (7315)............ I
Tetrahydrocannabinols (7370)................. I
Mescaline (7381)............................. I
3,4,5-Trimethoxyamphetamine (7390)........... I
4-Bromo-2,5-dimethoxyamphetamine (7391)...... I
4-Bromo-2,5-dimethoxyphenethylamine (7392)... I
4-Methyl-2,5-dimethoxyamphetamine (7395)..... I
2,5-Dimethoxyamphetamine (7396).............. I
2,5-Dimethoxy-4-ethylamphetamine (7399)...... I
3,4-Methylenedioxyamphetamine (7400)......... I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404). I
3,4-Methylenedioxymethamphetamine (7405)..... I
4-Methoxyamphetamine (7411).................. I
Bufotenine (7433)............................ I
Diethyltryptamine (7434)..................... I
Dimethyltryptamine (7435).................... I
Psilocybin (7437)............................ I
Psilocyn (7438).............................. I
Codeine-N-oxide (9053)....................... I
Dihydromorphine (9145)....................... I
Heroin (9200)................................ I
Morphine-N-oxide (9307)...................... I
Normorphine (9313)........................... I
Pholcodine (9314)............................ I
Acetylmethadol (9601)........................ I
Allyprodine (9602)........................... I
Alphacetylmethadol except Levo- I
Alphacetylmethadol (9603).
Alphameprodine (9604)........................ I
Alphamethadol (9605)......................... I
Betcetylmethadol (9607)...................... I
Betameprodine (9608)......................... I
Betamethadol (9609).......................... I
Betaprodine (9611)........................... I
Hydromorphinol (9627)........................ I
Noracymethadol (9633)........................ I
Norlevorphanol (9634)........................ I
Normethadone (9635).......................... I
Trimeperidine (9646)......................... I
Para-Fluorofentanyl (9812)................... I
3-Methylfentanyl (9813)...................... I
Alpha-methylfentanyl (9814).................. I
Acetyl-alpha-methylfentanyl (9815)........... I
Beta-hydroxyfentanyl (9830).................. I
Beta-hydroxy-3-methylfentanyl (9831)......... I
Alpha-Methylthiofentanyl (9832).............. I
3-Methylthiofentanyl (9833).................. I
Thiofentanyl (9835).......................... I
Amphetamine (1100)........................... II
Methamphetamine (1105)....................... II
[[Page 52531]]
Phenmetrazine (1631)......................... II
Methylphenidate (1724)....................... II
Amobarbital (2125)........................... II
Pentobarbital (2270)......................... II
Secobarbital (2315).......................... II
Glutethimide (2550).......................... II
Nabilone (7379).............................. II
1-Phenylcyclohexylamine (7460)............... II
Phencyclidine (7471)......................... II
1-Piperidinocoyclohexanecarbonitrile (8603).. II
Alphaprodine (9010).......................... II
Cocaine (9041)............................... II
Codeine (9050)............................... II
Dihydrocodeine (9120)........................ II
Oxycodone (9143)............................. II
Hydromorphone (9150)......................... II
Diphenoxylate (9170)......................... II
Benzoylecogonine (9180)...................... II
Ethylmorphine (9190)......................... II
Hydrocodone (9193)........................... II
Levomethorphan (9210)........................ II
Levorphanol (9220)........................... II
Isomethadone (9226).......................... II
Meperidine (9230)............................ II
Methadone (9250)............................. II
Methadone-intermediate (9254)................ II
Morphine (9300).............................. II
Levo-alphacetylmethadol (9648)............... II
Oxymorphone (9652)........................... II
Alfentanil (9737)............................ II
Sufentanil (9740)............................ II
Fentanyl (9801).............................. II
------------------------------------------------------------------------
The firm plans to manufacture small quantities of the listed
controlled substances to make deuterated and non-deuterated drug
reference standards which will be distributed to analytical and
forensic laboratories for drug testing programs.
No comments or objections have been received. DEA has considered
the factors in Title 21, United States Code, section 823(a) and
determined that the registration of Radian International LLC to
manufacture the listed controlled substances is consistent with the
public interest at this time. DEA has investigated Radian International
LLC on a regular basis to ensure that the company's continued
registration is consistent with the public interest. These
investigations have included inspection and testing of the company's
physical security systems, audits of the company's records,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant
Administrator, Office of Diversion Control, hereby orders that the
application submitted by the above firm for registration as a bulk
manufacturer of the basic classes of controlled substances listed above
is granted.
Dated: September 17, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 99-25359 Filed 9-28-99; 8:45 am]
BILLING CODE 4410-09-M